Literature DB >> 16437725

Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma.

Makoto Nakamuta1, Shusuke Morizono, Motoyuki Kohjima, Kazuhiro Kotoh, Munechika Enjoji.   

Abstract

AIM: To characterize the baseline profiles of patients aged 70 years and above with hepatocellular carcinoma (HCC).
METHODS: A series of 127 consecutive patients with HCC were enrolled between 2000 and 2004, and none of them had been diagnosed as having HCC previously. Baseline profiles, including parameters of hepatic function such as serum transaminase and prothrombin time [PT (% activity)] were compared between patients aged > or = 70 and < 70 years.
RESULTS: Patients > or = 70 years old showed significantly lower levels of aspartate aminotransferase (P = 0.04) and alanine aminotransferase (P = 0.01), and significantly higher PTs (P = 0.04) and platelet counts (P = 0.02). Concomitantly, among > or = 70-year-old patients, HCC was more common in non-cirrhotics, whereas among patients < 70 years old, HCC was more common in cirrhotics. There was no significant difference between the groups in the number or size of tumors.
CONCLUSION: Older HCC patients showed less inflammation and better preservation of hepatic function, indicating that not only cirrhotic patients but also non-cirrhotic patients should be considered as a high-risk group among the elderly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437725      PMCID: PMC4725168          DOI: 10.3748/wjg.v11.i47.7512

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

Review 1.  Aging biology and cancer.

Authors:  Neelima Denduluri; William B Ershler
Journal:  Semin Oncol       Date:  2004-04       Impact factor: 4.929

Review 2.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Trends in primary liver cancer.

Authors:  S Deuffic; T Poynard; L Buffat; A J Valleron
Journal:  Lancet       Date:  1998-01-17       Impact factor: 79.321

4.  Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.

Authors:  Yasushi Shiratori; Yoichi Ito; Osamu Yokosuka; Fumio Imazeki; Ryo Nakata; Naohide Tanaka; Yasuyuki Arakawa; Etsuko Hashimoto; Katsutaro Hirota; Haruhiko Yoshida; Yasuo Ohashi; Masao Omata
Journal:  Ann Intern Med       Date:  2005-01-18       Impact factor: 25.391

Review 5.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors:  Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 6.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

7.  Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management.

Authors:  R T Poon; S T Fan; C M Lo; C L Liu; H Ngan; I O Ng; J Wong
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

8.  Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

Authors:  Y Shiratori; S Shiina; M Imamura; N Kato; F Kanai; T Okudaira; T Teratani; G Tohgo; N Toda; M Ohashi
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

9.  Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis.

Authors:  Francesco Azzaroli; Esterita Accogli; Giovanni Nigro; Davide Trere; Silvia Giovanelli; Anna Miracolo; Francesca Lodato; Marco Montagnani; Mariarosa Tamé; Antonio Colecchia; Constance Mwangemi; Davide Festi; Enrico Roda; Massimo Derenzini; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

10.  Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival.

Authors:  Franco Trevisani; Maria C Cantarini; Antonello M M Labate; Stefania De Notariis; Gianludovico Rapaccini; Fabio Farinati; Paolo Del Poggio; Maria Anna Di Nolfo; Luisa Benvegnù; Marco Zoli; Franco Borzio; Mauro Bernardi
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

View more
  2 in total

1.  Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more.

Authors:  Koichi Oishi; Toshiyuki Itamoto; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  J Gastrointest Surg       Date:  2008-12-03       Impact factor: 3.452

2.  Liver resection in hepatitis B related-hepatocellular carcinoma: clinical outcomes and safety in elderly patients.

Authors:  Hai-Qing Wang; Jian Yang; Lu-Nan Yan; Xiao-Wu Zhang; Jia-Yin Yang
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.